Translate

FREQUENTLY ASKED QUESTIONS (FAQ)

 

Loan Against Listed Shares (LASS)

Institutional Securities-Backed Financing

1. What is a Loan Against Listed Shares (LASS)?

Loan Against Listed Shares (LASS), also known as Securities-Based Lending (SBL), is an institutional financing solution that enables qualified borrowers to obtain liquidity by pledging eligible publicly listed shares as collateral instead of selling them.

This financing structure allows borrowers to unlock capital while preserving ownership of their investment portfolio.

2. Who is eligible to apply?

The financing program is generally designed for:

  • Publicly Listed Companies
  • Major Shareholders
  • Company Founders
  • Family Offices
  • High-Net-Worth Individuals (HNWIs)
  • Institutional Investors
  • Investment Holding Companies
  • Corporate Executives holding significant listed shares

All applications remain subject to lender approval.

3. Do I need to sell my shares?

No.

One of the principal advantages of Loan Against Listed Shares is that you retain your investment while using it as collateral.

There is no need to liquidate your portfolio simply to obtain financing.

4. Will I lose ownership of my shares?

No.

You remain the beneficial owner of your shares throughout the financing period, subject to the agreed loan structure and lender requirements.

Your investment continues to participate in future market appreciation.

5. How much financing can I obtain?

Qualified borrowers may obtain financing of up to 70% Loan-to-Value (LTV).

The final financing amount depends on:

  • Market value
  • Liquidity
  • Market capitalization
  • Daily trading volume
  • Price volatility
  • Portfolio diversification
  • Institutional lender's assessment

6. What interest rate can I expect?

Indicative institutional financing rates generally range from 2% to 4% per annum (APR).

The final rate depends on:

  • Quality of the listed shares
  • Liquidity
  • Market capitalization
  • Portfolio value
  • Transaction size
  • Borrower profile
  • Lender's credit assessment

Higher-quality listed shares generally qualify for more competitive financing terms.

7. Are there any upfront fees?

For qualified transactions, there are generally no upfront financing fees before loan approval and closing.

If legal, custody, documentation, or third-party costs apply, they will be fully disclosed during the due diligence process.

8. How quickly can funding be completed?

When all required documents have been submitted and the transaction satisfies the lender's requirements, funding may be completed within 1–3 business days after:

  • Due diligence completion
  • Loan approval
  • Legal documentation
  • Closing conditions

9. Which stock exchanges are generally acceptable?

Eligibility depends on the lender.

Many institutional lenders may consider eligible shares listed on recognized exchanges such as:

  • NYSE
  • NASDAQ
  • London Stock Exchange (LSE)
  • Singapore Exchange (SGX)
  • Hong Kong Stock Exchange (HKEX)
  • Australian Securities Exchange (ASX)
  • Bursa Malaysia
  • Indonesia Stock Exchange (IDX)
  • Tokyo Stock Exchange (TSE)

Final eligibility depends on lender criteria.

10. What types of shares are preferred?

Institutional lenders generally prefer shares with:

  • Strong liquidity
  • Large market capitalization
  • Stable trading history
  • Active daily trading volume
  • Broad institutional ownership

11. What can the financing be used for?

Loan proceeds may generally be used for legitimate business purposes such as:

  • Working Capital
  • Rights Issues
  • Mergers & Acquisitions
  • Business Expansion
  • Debt Refinancing
  • Project Development
  • Capital Expenditure (CAPEX)
  • Strategic Investments

subject to the applicable loan agreement and regulations.

12. Is there a minimum portfolio value?

Minimum portfolio requirements vary depending on the institutional lender and transaction structure.

During the initial assessment, the lender evaluates whether the portfolio size and quality meet its financing criteria.

13. Is the loan non-recourse?

Certain financing structures may be offered on a non-recourse basis, subject to lender approval and the final transaction structure.

Availability depends on the quality of the pledged securities and the lender's policies.

14. Can dividends still be received?

Treatment of dividends depends on the final financing structure and loan agreement.

The lender will explain how dividend distributions are handled before the transaction is finalized.

15. What happens if the share price declines?

Institutional lenders continuously monitor the collateral value.

If market prices decline significantly, additional collateral or other remedial actions may be required under the loan agreement.

The exact terms are clearly defined in the financing documentation.

16. Is my information confidential?

Yes.

All enquiries, documentation, and transactions are handled under strict confidentiality.

PT Nurin Inti Global and its lending partners comply with applicable KYC, AML, and institutional compliance standards.

17. What documents are typically required?

Typical documentation may include:

  • Application Form
  • Passport or National ID
  • Portfolio Statement
  • Proof of Share Ownership
  • Corporate Documents (for companies)
  • Banking Information
  • KYC Documentation
  • Additional supporting documents requested by the lender

18. Is PT Nurin Inti Global the lender?

No.

PT Nurin Inti Global acts solely as an independent:

  • Financial Advisor
  • Financial Introducer
  • Transaction Facilitator

We connect qualified borrowers with reputable international institutional lenders.

19. How does the application process work?

The process is straightforward:

Step 1
Initial enquiry by email.

Step 2
Receive the Application Form.

Step 3
Complete the Application Form.

Step 4
Sign the Engagement Letter and related documents electronically.

Step 5
Submit the completed application package together with supporting documents.

Step 6
Institutional lender conducts portfolio evaluation and due diligence.

Step 7
Conditional Approval and Term Sheet are issued.

Step 8
Execution of the final loan documentation.

Step 9
Funds are disbursed to the designated bank account.

Qualified transactions may be completed within 1–3 business days after all documentation and closing conditions have been satisfied.

20. How do I get started?

Simply contact PT Nurin Inti Global.

Our team will:

  • Explain the financing process
  • Provide the Application Form
  • Review your preliminary eligibility
  • Coordinate with our institutional lending partners
  • Assist throughout the transaction until completion

Contact Us

PT Nurin Inti Global

Institutional Securities-Backed Financing

AHMAD FAKAR
Financial Introducer

📧 Email:
nuringlobal@gmail.com

📱 WhatsApp:
+62 813 686 43249

Back to main menu click here 

at26914806